Sackler family receives immunity in $6 billion opioid settlement

The Sackler family, owners of Purdue Pharma, will receive immunity from all current and future civil claims related to the company's role in the opioid crisis.
Purdue Pharma will be dissolved and restructured into a new entity known as Knoa Pharma,overseen by a public board and manufacturing medications for addiction treatment and OxyContin.
About $750 million from the settlement will go to families and individuals affected by the opioid crisis, with payments ranging from $3,500 to $48,000.
The ruling by a New York appeals court clears the way for Purdue Pharma's bankruptcy deal and protects the Sacklers from lawsuits over the toll of opioids.
Purdue Pharma misleadingly marketed Oxycontin as nonaddictive, contributing to an opioid crisis that has killed over a million Americans.